{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:22:54Z","timestamp":1789381374500,"version":"build-2803163510"},"reference-count":146,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Medicine. Therapeutics"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:p> Sustained inhibition of HIV-1, the goal of antiretroviral therapy, is often impeded by the emergence of viral drug resistance. For patients infected with HIV-1 resistant to conventional drugs from the viral reverse transcriptase and protease inhibitor classes, the recently approved entry and integration inhibitors effectively suppress HIV-1 and offer additional therapeutic options. Entry inhibitors are particularly attractive because, unlike conventional antiretrovirals, they target HIV-1 extracellularly, thereby sparing cells from both viral- and drug-induced toxicities. The fusion inhibitor enfuvirtide and the CCR5 antagonist maraviroc are the first entry inhibitors licensed for patients with drug-resistant HIV-1, with maraviroc restricted to those infected with CCR5-tropic HIV-1 (R5 HIV-1) only. Vicriviroc (another CCR5 antagonist) is in Phase III clinical trials, whereas the CCR5 antibodies PRO 140 and HGS 004 are in early stages of clinical development. Potent antiviral synergy between maraviroc and CCR5 antibodies, coupled with distinct patterns of resistance, suggest their combinations might be particularly effective in patients. In addition, given that oral administration of maraviroc achieves high drug levels in cervicovaginal fluid, combinations of maraviroc and other CCR5 inhibitors could be effective in preventing HIV-1 transmission. Moreover, since CCR5 antagonists prevent rejection of transplanted organs, maraviroc could both suppress HIV-1 and prolong organ survival for the growing number of HIV-1 patients with kidney or liver failure necessitating organ transplantation. Thus, maraviroc offers an important treatment option for patients with drug-resistant R5 HIV-1, who presently account for &gt;50% of drug-resistance cases. <\/jats:p>","DOI":"10.4137\/cmt.s2365","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T14:38:38Z","timestamp":1509719918000},"source":"Crossref","is-referenced-by-count":3,"title":["Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc"],"prefix":"10.4137","volume":"1","author":[{"given":"Olga","family":"Latinovic","sequence":"first","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaki","family":"Kuruppu","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Davis","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhut","family":"Le","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonso","family":"Heredia","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2009,10,13]]},"reference":[{"key":"bibr1-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"bibr2-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1080\/09540120220123685"},{"key":"bibr3-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200111230-00010"},{"key":"bibr4-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.48.113006.094847"},{"key":"bibr5-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0503-470"},{"issue":"4","key":"bibr6-CMT.S2365","first-page":"18","volume":"18","author":"Vazquez E.","year":"2007","journal-title":"Posit Aware."},{"key":"bibr7-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1086\/518797"},{"key":"bibr8-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1086\/592169"},{"key":"bibr9-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1086\/527327"},{"key":"bibr10-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00942-08"},{"key":"bibr11-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60497-8"},{"key":"bibr12-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60597-2"},{"key":"bibr13-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035026"},{"key":"bibr14-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.5.555"},{"key":"bibr15-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.11.4721-4732.2005"},{"key":"bibr16-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5270.1955"},{"key":"bibr17-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81313-6"},{"key":"bibr18-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1038\/381661a0"},{"key":"bibr19-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1038\/381667a0"},{"key":"bibr20-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5243.1811"},{"key":"bibr21-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.9.5215"},{"key":"bibr22-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1038\/nm0397-338"},{"key":"bibr23-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1038\/nm1097-1160"},{"key":"bibr24-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1086\/431519"},{"key":"bibr25-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5263.872"},{"key":"bibr26-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1086\/428096"},{"key":"bibr27-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80110-5"},{"issue":"5328","key":"bibr28-CMT.S2365","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.277.5328.959","volume":"277","author":"Smith M.W.","year":"1997","journal-title":"Science."},{"key":"bibr29-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1126\/science.1118398"},{"key":"bibr30-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.090576697"},{"key":"bibr31-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1124\/mol.107.042101"},{"key":"bibr32-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M512688200"},{"key":"bibr33-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.01.018"},{"key":"bibr34-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.9.5201-5208.2003"},{"key":"bibr35-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.1.139"},{"key":"bibr36-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.8.1215"},{"key":"bibr37-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.4.2855-2864.1998"},{"key":"bibr38-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.7.4347-4356.2005"},{"key":"bibr39-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.252469399"},{"key":"bibr40-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.10.5476-5485.2004"},{"issue":"4","key":"bibr41-CMT.S2365","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.4049\/jimmunol.163.4.2306","volume":"163","author":"Hladik F.","year":"1999","journal-title":"J Immunol."},{"key":"bibr42-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1086\/315315"},{"key":"bibr43-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32815278ea"},{"key":"bibr44-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01602-06"},{"key":"bibr45-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2005.07.006"},{"key":"bibr46-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1834278100"},{"key":"bibr47-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0810843106"},{"key":"bibr48-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.5.1925"},{"key":"bibr49-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.49.30662"},{"key":"bibr50-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1998.14.1509"},{"key":"bibr51-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.9.5668"},{"key":"bibr52-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M008391200"},{"key":"bibr53-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1126\/science.1101160"},{"key":"bibr54-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1998.9082"},{"key":"bibr55-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1038\/nm0496-412"},{"key":"bibr56-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/01.qco.0000200293.45532.68"},{"key":"bibr57-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1038\/nature01188"},{"key":"bibr58-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1038\/nm1319"},{"key":"bibr59-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.4911-4919.2005"},{"key":"bibr60-CMT.S2365","unstructured":"AbelS., van der RystE., MuirheadG. Pharmacokinetics of single and multiple oral doses of UK-427,857\u2014a novel CCR5 antagonist in healthy volunteers. In: Abstracts of the Tenth Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2003. Alexandria, VA, USA: Foundation for Retrovirology and Human Health. 2003; Abstract 547."},{"key":"bibr61-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03137.x"},{"key":"bibr62-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03134.x"},{"key":"bibr63-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03133.x"},{"key":"bibr64-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1080\/00498250802447409"},{"issue":"10","key":"bibr65-CMT.S2365","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1021\/jm0304515","volume":"47","author":"Tagat J.R.","year":"2004","journal-title":"J Med Chem."},{"key":"bibr66-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3280f00f9f"},{"key":"bibr67-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.002626"},{"key":"bibr68-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005683"},{"key":"bibr69-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00444-08"},{"key":"bibr70-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.10.4909-4920.2006"},{"key":"bibr71-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.6.1374"},{"key":"bibr72-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.70.8.5487-5494.1996"},{"key":"bibr73-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000233569.74769.69"},{"key":"bibr74-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282ef81ea"},{"key":"bibr75-CMT.S2365","unstructured":"HarriganP.R., McGovernR., DongW. Screening for HIV Tropism Using Population-Based V3 Genotypic Analysis: A Retrospective Virological Outcome Analysis Using Stored Plasma Screening Samples From MOTIVATE 1. 18th HIV Drug Resistance Workshop. 2009 June 9-12, Ft. Myers Florida. 2009."},{"key":"bibr76-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832b4399"},{"key":"bibr77-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0803154"},{"key":"bibr78-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0803152"},{"key":"bibr79-CMT.S2365","unstructured":"GoodrichJ.M., SaagM., van der RystE. 48-week safety and efficacy of maraviroc, a novel CCR5 antagonist, in combination with optimized background therapy (OBT) for the treatment of antiretroviral-experienced patients infected with dual\/mixed-tropic HIV-1. Program and abstracts of the 45th Annual Meeting of the Infectious Disease Society of America, 2007 October 4-7, San Diego, CA (Abstract LB-2)."},{"key":"bibr80-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1086\/598965"},{"key":"bibr81-CMT.S2365","unstructured":"SaagM., PrudenceI., HeeraJ. A multicenter, randomized, double-blind, comparative trial of a novel CCR5 antagonist, maraviroc versus efavirenz, both in combination with Combivir (zidovudine [ZDV]\/lamivudine [3TC]), for the treatment of antiretroviral naive patients infected with R5 HIV 1: week 48 results of the MERIT study. Abstracts of the Fourth International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, Australia. Abstract WESS 104. 2007."},{"key":"bibr82-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp113"},{"key":"bibr83-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00821-07"},{"key":"bibr84-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1086\/592052"},{"key":"bibr85-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02006-06"},{"key":"bibr86-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.11.004"},{"key":"bibr87-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.6.2790-2807.2004"},{"key":"bibr88-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.04.035"},{"key":"bibr89-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2007.12.009"},{"key":"bibr90-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000548"},{"key":"bibr91-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00385-07"},{"key":"bibr92-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01751-08"},{"key":"bibr93-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0811713106"},{"issue":"2","key":"bibr94-CMT.S2365","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/135965350801300211","volume":"13","author":"Mascolini M.","year":"2008","journal-title":"Antivir Ther."},{"key":"bibr95-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2008.04.032"},{"key":"bibr96-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.16.8654-8662.2004"},{"key":"bibr97-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.008565"},{"key":"bibr98-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2007.12.003"},{"key":"bibr99-CMT.S2365","author":"Schering-Plough","year":"2009","journal-title":"Press Release"},{"issue":"9","key":"bibr100-CMT.S2365","first-page":"385","volume":"12","author":"Hoffmann C.","year":"2007","journal-title":"Eur J Med Res."},{"key":"bibr101-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099288"},{"key":"bibr102-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031266"},{"key":"bibr103-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1086\/598685"},{"key":"bibr104-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030351"},{"key":"bibr105-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1038\/nature04055"},{"key":"bibr106-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1038\/nm1321"},{"key":"bibr107-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181ae69c5"},{"key":"bibr108-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000247578.08449.ff"},{"key":"bibr109-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1086\/313843"},{"key":"bibr110-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282ef1bb4"},{"key":"bibr111-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00686.x"},{"key":"bibr112-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20534"},{"key":"bibr113-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-6-200609190-00003"},{"key":"bibr114-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00245.x"},{"key":"bibr115-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.02061.x"},{"key":"bibr116-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000075973.73064.A6"},{"issue":"6","key":"bibr117-CMT.S2365","first-page":"559","volume":"35","author":"Carlson L.","year":"2008","journal-title":"Nephrol Nurs J."},{"key":"bibr118-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.02007.x"},{"key":"bibr119-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199908150-00002"},{"key":"bibr120-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1086\/591459"},{"key":"bibr121-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-009-0007-y"},{"key":"bibr122-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1086\/343048"},{"key":"bibr123-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.2008.508"},{"key":"bibr124-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308185100"},{"key":"bibr125-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2008.05.006"},{"key":"bibr126-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04898-4"},{"key":"bibr127-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000166338.99933.e1"},{"key":"bibr128-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.4.2289"},{"key":"bibr129-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283136d95"},{"key":"bibr130-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030218"},{"key":"bibr131-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200305230-00010"},{"key":"bibr132-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl306"},{"key":"bibr133-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1086\/587693"},{"key":"bibr134-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000183633.06580.8a"},{"key":"bibr135-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1124\/mol.107.035055"},{"key":"bibr136-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00699-06"},{"key":"bibr137-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.5.4145-4155.1999"},{"key":"bibr138-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.05.016"},{"key":"bibr139-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1086\/504693"},{"key":"bibr140-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M009779200"},{"key":"bibr141-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1007\/BF02696657"},{"key":"bibr142-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.02.199"},{"key":"bibr143-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1038\/nm0703-847"},{"key":"bibr144-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1932511100"},{"key":"bibr145-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-5-111"},{"key":"bibr146-CMT.S2365","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e3280142007"}],"container-title":["Clinical Medicine. Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4137\/CMT.S2365","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.4137\/CMT.S2365","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4137\/CMT.S2365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T03:51:08Z","timestamp":1729137068000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.4137\/CMT.S2365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":146,"alternative-id":["10.4137\/CMT.S2365"],"URL":"https:\/\/doi.org\/10.4137\/cmt.s2365","relation":{},"ISSN":["1179-1713"],"issn-type":[{"value":"1179-1713","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"article-number":"CMT.S2365"}}